In the past few years, CBD has emerged as a popular and effective medical supplement. It can provide a wide range of benefits for users, from anti-anxiety effects to insomnia management. CBD is also widely used to treat chronic pain conditions too.
But those unfamiliar with CBD often struggle to manage their intake and find the right dosage for them. CBD is still relatively new, and there are myriad factors to take into account when you’re starting it for the first time.
Read on to discover how to find the best CBD dosage for you so you can start enjoying chronic pain relief today.
According to the Anxiety and Depression Association of America, anxiety disorders are the most common mental complications in the United States affecting more than 40 million adults in the US or at least 18% of the population every year. Although anxiety disorders are highly treatable, only about 36% of anxiety patients receive treatment.
Several factors can lead to anxiety. Some of these factors include brain chemistry, genetics, personality, and drastic life changes. We are all, therefore, prone to anxiety.
Anxiety affects us differently. Some people might feel unprepared, unsure, or nervous when trying something new or before giving a speech. These feelings may manifest in physical symptoms such as headaches, shortness of breath, or clammy hands.
Anxiety is actually an adaptive response that can help us cope with challenges or day to day threats. These responses can help identify and avert potential threats, encourage us to work harder, etc. However, when we don’t respond well to these triggers, they can become maladaptive leading to clinical anxiety disorders.
Cannabidiol (CBD) is an exciting focus of medical research, popular media, and legislation related to cannabis. Its presence is becoming ubiquitous on the shelves of health food stores and search engine results for numerous medical conditions, but don’t believe everything you hear. While CBD is an incredibly safe and therapeutic component of cannabis, there are many myths and misconceptions associated with it. Let’s take a look at a few.
Myth #1: CBD is non-psychoactive and medical; THC is recreational.
Both lay and scientific literature have classified CBD as a “non-psychoactive” substance, meaning that it does not alter one’s consciousness. But how could CBD fail to impact consciousness when it’s been shown to have anti-anxiety, anti-psychotic, anti-craving, alerting, and mood-elevating effects in human studies?
CBD clearly impacts our psyche, often in beneficial ways. It does not, however, impair mental or physical function in most consumers, even very high doses. Thus, CBD can be considered psychoactive, but “non-impairing” or “non-intoxicating.”
Dosage is the key factor in achieving the most benefits and least adverse effects of cannabis. After following thousands of patients using medical cannabis for eight years, I’ve observed that dosing cannabis is unlike any therapeutic agent to which I was exposed in my medical training. A basic understanding of the key characteristics of cannabis dosing can empower you to make the most of this incredibly versatile, safe, and effective herb.
- According to a U.S. government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”
- A 2014 study found that traumatic brain injury (TBI) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana.
- Preclinical research and anecdotal accounts indicate that CBD is highly active against brain ischemia, modulating many of the molecular hallmarks of TBI pathology.
- CBD normalizes post-ischemic heart arrhythmia and limits the size of damaged brain tissue in mice when administered shortly before or after a closed head injury.
- CBD produces no intoxicating effects, no THC-like high, and its use does not lead to tolerance.
- As yet there have been no FDA-approved clinical trials to determine the efficacy of CBD-rich cannabis oil extracts for traumatic brain injury.
The U.S. Drug Enforcement Administration has taken some cannabidiol out of the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.
It’s a decision that immediately affects CBD producers but also signals the agency’s first admission that the plant has medical value.
The DEA announced Thursday that drugs including CBD with THC content below 0.1% are now considered Schedule 5 drugs, as long as they have been approved by the U.S. Food and Drug Administration.
It is the first time the agency has lowered any type of cannabis from Schedule 1.
The cannabis plant contains a number of compounds with research-backed benefits for cancer patients. The science-based case that it is a safe and effective medicine will be made below, with plenty of links to double-blind studies, authoritative sources, and leading experts. The takeaway being that the plant and preparations derived from it can provide relief of cancer-related symptoms like pain, nausea, and inflammation. Some research has even shown that some cannabis compounds may slow cancer growth and shrink tumors.